Press Release / Media Release
Mumbai, January 22, 2018: Lasa Supergenerics Limited (BSE: 540702, NSE: LASA) LASA gets enlisted as 'First Choice Customer' with CIDIC - among large pharma companies in China22-01-2018
22-01-2018
Shareholding for the Period Ended December 31, 2017
Lasa Supergenerics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click here17-01-2018
Statement Of Investor's Complaints For The Quarter Ended December 31,2017
Disclosure u/r 13(3) of SEBI (LODR) Regulations,201515-01-2018
Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Omkar P Herlekar12-01-2018
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Omkar Pravin Herlekar12-01-2018
Updates
Intimation as per Regulation 10(6) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 201112-01-2018
Updates
Disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 201112-01-2018
Extra Ordinary General Meeting On February 07 2018 At 11.00 Am
Extra Ordinary General Meeting of Lasa Supergenerics Limited will be held at Registered Office of the company C-105, MIDC, Mahad, Dist- Raigad, Mahad-402 309 on February 07 2018 at 11.00 am12-01-2018
Outcome of Board Meeting
Approved the Notice to convene Extra Ordinary General Meeting scheduled to be held on Wednesday February 07, 2018 at 11.00 am09-01-2018